Tuesday, 02 January 2024 12:17 GMT

Gainey Mckenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Synopsys, Inc. (SNPS)


(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased or otherwise acquired Synopsys, Inc. (“Synopsys” or the“Company”) (NASDAQ: SNPS) securities between December 4, 2024 and September 9, 2025, inclusive (the“Class Period”).

The Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that: (1) the extent to which the Company's increased focus on artificial intelligence customers, which require additional customization, was deteriorating the economics of its Design IP business; (2) that, as a result,“certain road map and resource decisions” were unlikely to“yield their intended results;” (3) that the foregoing had a material negative impact on financial results; and (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Investors who purchased or otherwise acquired shares of Synopsys should contact the Firm prior to the December 30, 2025 lead plaintiff motion deadline. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to discuss your rights or interests regarding this class action, please contact Thomas J. McKenna, Esq. or Gregory M. Egleston, Esq. of Gainey McKenna & Egleston at (212) 983-1300, or via e-mail at ... or ....

Please visit our website at for more information about the firm.


MENAFN03112025004107003653ID1110289912



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search